Institut de Neurociències (INc) - UAB Barcelona

Dr. Raül Andero received the ICREA Research Professor distinction

Dr. Raül Andero received the ICREA Research Professor distinction

Dr. Raül Andero,coordinator of the Translational mechanisms of fear memory laboratory, has been granted a Senior Research Professor position, awarded by the Catalan Institution for Research and Advanced Studies (ICREA).

04/12/2020

Raül Andero, researcher at the Institute and assistante professor at the Department of Psychobiology and Methodology of Health Sciences, has been awarded an ICREA Research Professor – Full Professor - distinction by the Catalan Institution for Research and Advanced Studies (ICREA). This senior distinction aims to promote and develop scientific, humanistic and technological research for the benefit of society. Raül Andero has been distinguished for his research excellence in the field of Social and Behavioral Sciences.

Raül Andero is a neuroscientist specializing in the study of behavior. Especifically, he studies those mental disorders related to a stressful event, due to alterations in the memory of fear. His objective is to understand the molecular mechanisms involved, and the sexual differences that exist in these circuits, in order to develop effective treatments for anxiety and fear-based disorders, such as post-traumatic stress disorder, panic disorder or specific phobias.

Dr. Andero obtained his PhD in Neurosciences at UAB, studying stress and memory with animal models. Afterwards, he joined Dr. Ressler's lab, at the Emory University in the United States, and later, at the Harvard Medical School, where he combined studies with psychiatric patients and animal models of fear memory. Since 2016, he has been leading the Translational mechanisms of fear memory laboratory at the Institute, as a Ramón y Cajal researcher and, since 2021, as an ICREA Research Professor.

Currently, Dr. Andero coordinates the ERA-NET NEURON H2020 Translational Biomarkers of Traumatic Stress project, which includes the Harvard University, the University of Göttingen, the École polytechnique fédérale de Lausanne and the Parc Taulí Foundation. The aim of the project is to conduct a translational study, including animal models and studies with patients, on post-traumatic stress disorder.



Related news

The H2020 project QSPainRelief awarded by the European Commission

The H2020 project QSPainRelief awarded by the European Commission

The QSPainRelief project "Effective combinational treatment of chronic pain in individual patients by an innovative quantitative systems pharmacology pain relief approach", which includes the participation of Dr. Jesús Giraldo’s team (Institute for Neurosciences and Biostatistics Unit of the School of Medicine), has been funded from the European Commission.

This  project will attempt to solve a crucial problem since about 20% of Europeans suffer from chronic pain and current therapies are not effective in many cases. Around 60% of patients do not reach enough relief from traditional painkillers, which in turn can lead to several adverse effects.

The QSPainRelief project addresses the problem of chronic pain by identifying new drug combinations that are expected to increase analgesic efficacy while reducing side effects. To do this, quantitative systems pharmacology and computational modeling will be used. The best combinations will be validated in animal models and clinical studies.

The QSPainRelief project will receive more than € 6 million in funding for 5 years through the H2020 program. The project is a collaboration between 9 research institutions from 6 different countries, including the UAB, starting January 1, 2020.

A new model of the worm C. elegans to progress in the study of a rare disease of the nervous system

A new model of the worm C. elegans to progress in the study of a rare disease of the nervous system

In a research co-directed by Dr Esther Dalfó, researcher at the Institute and professor at UVic-UCC, a model of chromosome X-linked adrenoleukodystrophy (x-ALD) has been indentified in the earthworm C. elegans.

The model will permit to accelerate and reduce the price of the research, which is studying the mechanisms and the possible pharmacological targets for the neuronal alterations of this disease.

The earliest results of studies with this organism point to glial cells as a man responsible for the neurological damage caused by the disease.

The work was done at the IDIBELL Neurometabolic Diseases group, with international collaborations, and has been published in the Free Radical Biology and Medicine journal.

Read the article

View all news